These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2544349)

  • 21. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
    Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
    Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Results of trimodality therapy in patients with stage IIIA (N2-bulky) and stage IIIB non-small-cell lung cancer.
    Li J; Dai CH; Yu LC; Chen P; Li XQ; Shi SB; Wu JR
    Clin Lung Cancer; 2009 Sep; 10(5):353-9. PubMed ID: 19808194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.
    Stathopoulos GP; Dafni UG; Malamos NA; Rigatos S; Kouvatseas G; Moschopoulos N
    Anticancer Res; 1999; 19(4C):3543-8. PubMed ID: 10629650
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
    Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial.
    Burkes RL; Ginsberg RJ; Shepherd FA; Blackstein ME; Goldberg ME; Waters PF; Patterson GA; Todd T; Pearson FG; Cooper JD
    J Clin Oncol; 1992 Apr; 10(4):580-6. PubMed ID: 1312587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer.
    Woods RL; Williams CJ; Levi J; Page J; Bell D; Byrne M; Kerestes ZL
    Br J Cancer; 1990 Apr; 61(4):608-11. PubMed ID: 1691921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cisplatin, doxorubicin and vindesine in the treatment of advanced non-small cell lung cancer].
    Akiyama J; Sato A; Honda K; Chida K; Watanabe T; Okano H; Okano A; Taniguchi M; Genma H; Aoki H
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):419-24. PubMed ID: 1848420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent 5-fluorouracil, leucovorin, etoposide, cisplatin and radiotherapy for locally advanced non-small cell lung cancer.
    Yang CT; Chang WC; Chen LH; Leung WM; Lee CH; Liaw CC
    Changgeng Yi Xue Za Zhi; 1997 Sep; 20(3):187-94. PubMed ID: 9397609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. European experience with ifosfamide in non-small cell lung cancer.
    Drings P
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):22-30. PubMed ID: 2539645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Results of a randomized study comparing combination of navelbine-cisplatin to combination of vindesine-cisplatin and to navelbine alone in 612 patients with inoperable non-small cell lung cancer].
    Le Chevalier T; Brisgand D; Pujol JL; Douillard JY; Monnier A; Rivière A; Chomy P; Le Groumellec A; Ruffie P; Gottfried M; Gaspard MH; Chevreau C; Alberola V; Cigolari S; Besson F; Martinez A; Besenval M; Berthaud P; Tursz T
    Bull Cancer; 1996 May; 83(5):385-94. PubMed ID: 8680091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multimodality treatment of non-small cell lung cancer: response to cisplatin, VP-16, and 5-FU chemotherapy and to surgery and radiation therapy.
    Sridhar KS; Thurer R; Kim Y; Fountzilas G; Davila E; Donnelly E; Charyulu KK; Saldana MJ; Thompson T; Benedetto P
    J Surg Oncol; 1988 Jul; 38(3):193-215. PubMed ID: 2839738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial.
    Eberhardt W; Wilke H; Stamatis G; Stuschke M; Harstrick A; Menker H; Krause B; Müeller MR; Stahl M; Flasshove M; Budach V; Greschuchna D; Konietzko N; Sack H; Seeber S
    J Clin Oncol; 1998 Feb; 16(2):622-34. PubMed ID: 9469351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cisplatin, etoposide, and vincristine combination chemotherapy in the treatment of non-small cell lung cancer.
    Watanabe A; Ichiyama S; Shimokata K; Nagura E; Saito H; Saka H; Nomura F; Sakai S; Saito H
    Nagoya J Med Sci; 1993 Mar; 55(1-4):41-6. PubMed ID: 8247105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancer.
    Gridelli C; Pepe R; Palmeri S; Iacobelli S; Gentile M; Gebbia V; Garufi C; Airoma G; Palmieri G; Russo A
    Cancer Chemother Pharmacol; 1991; 28(5):405-7. PubMed ID: 1655301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two cycles of cisplatin-vindesine and radiotherapy for localized nonsmall cell carcinoma of the lung (stage III). Results of a prospective trial with 149 patients.
    Tourani JM; Timsit JF; Delaisement C; Balzon JC; Caubarrere I; Darse J; Geraads A; Lebas FX; Andrieu JM
    Cancer; 1990 Apr; 65(7):1472-7. PubMed ID: 2155697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.
    Bonomi P; Kim K; Fairclough D; Cella D; Kugler J; Rowinsky E; Jiroutek M; Johnson D
    J Clin Oncol; 2000 Feb; 18(3):623-31. PubMed ID: 10653877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential combined modality therapy for stage III non-small cell lung cancer.
    Vokes EE
    Hematol Oncol Clin North Am; 1990 Dec; 4(6):1133-42. PubMed ID: 1962780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Féderation Nationale des Centres de Lutte contre le Cancer) and the CEBI trialists.
    Arriagada R; Le Chevalier T; Quoix E; Ruffie P; de Cremoux H; Douillard JY; Tarayre M; Pignon JP; Laplanche A
    Int J Radiat Oncol Biol Phys; 1991 Jun; 20(6):1183-90. PubMed ID: 1646194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined modality treatment for locally advanced non-small cell lung cancer: preoperative chemoradiation does not result in a poorer quality of life.
    Schumacher A; Riesenbeck D; Braunheim M; Wewers D; Heinecke A; Semik M; Hoffknecht P; Macha HN; Klinke F; Schmidt EW; Willich N; Berdel WE; Thomas M;
    Lung Cancer; 2004 Apr; 44(1):89-97. PubMed ID: 15013587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective and randomized study of radiotherapy, sequential chemotherapy radiotherapy and concomitant chemotherapy-radiotherapy in unresectable non small cell carcinoma of the lung.
    Dasgupta A; Dasgupta C; Basu S; Majumdar A
    J Cancer Res Ther; 2006; 2(2):47-51. PubMed ID: 17998674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.